HDP1:FRA
Arrowhead Pharmaceuticals Inc
€54.58
arrow_downward
-0.15%(-0.080) 1D
Nov 5, 8:10:02 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HDP1...
Open
€54.58
High
€54.58
Low
€54.58
Mkt. cap
8.71B
Avg. vol.
5.00
Volume
0.00
52-wk high
€80.72
52-wk low
€32.38
No. of employees
711
Open
€54.58
High
€54.58
Low
€54.58
Mkt. cap
8.71B
Avg. vol.
5.00
Volume
0.00
52-wk high
€80.72
52-wk low
€32.38
No. of employees
711
News stories
From web sources and news partners
JHNewsAndGuide.com
·
1 hour ago
Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections
Serrari Group
·
30 minutes ago
Dow Surges 1,569 Points as Election Reshapes Wall Street
TradingView
·
1 hour ago
DJI: Dow Jones Jumps 3% in Stunning Post-Election Turnaround, AI Stocks Miss Out
Moomoo
·
2 hours ago
$Nasdaq Composite Index (.IXIC.US)$
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Industry-
Websitearrowheadpharma.com